A Meta-Analysis of PCSK9 Inhibitors Versus Statins for LDL Cholesterol Reduction and Cardiovascular Outcomes. (2025). Cardiology and Cardiovascular Medicine, 9(6), 491-498. https://fortunejournals.org/ojs/index.php/ccm/article/view/16664